Investors Hangout Stock Message Boards Logo
  • Mailbox
  • Favorites
  • Boards
    • The Hangout
    • NASDAQ
    • NYSE
    • OTC Markets
    • All Boards
  • Whats Hot!
    • Recent Activity
    • Most Viewed Boards
    • Most Viewed Posts
    • Most Posted
    • Most Followed
    • Top Boards
    • Newest Boards
    • Newest Members
  • Blog
    • Recent Blog Posts
    • Recently Updated
    • News
    • Stocks
    • Crypto
    • Investing
    • Business
    • Markets
    • Economy
    • Real Estate
    • Personal Finance
  • Market Movers
  • Interactive Charts
  • Login - Join Now FREE!
  1. Home ›
  2. Stock Message Boards ›
  3. Stock Boards ›
  4. CytoDyn Inc (CYDY) Message Board

"Question for the board. When we get an indication

Message Board Public Reply | Private Reply | Keep | Replies (0)                   Post New Msg
Edit Msg () | Previous | Next


Post# of 154977
(Total Views: 596)
Posted On: 12/12/2024 9:35:43 PM
Posted By: Buddyboy20
Re: Ramjet #148672
"Question for the board. When we get an indication approved, say the ART-bNAB-LL combination drug HIV cure, could a board-certified doctor prescribe it for any off-label use, say Alzheimer's?

Or are there limitations on that?"

Google's AI response says yes. There does not seem to be much limitation. However, for his/her own protection, I'm sure that they would be able to justify why they used it. Also, there might be limitations within their corporate affiliation. Additionally, insurance may have more to say about it, than anyone.

Here is the AI response:

Yes, a doctor can legally use a drug to treat a different indication than what it is officially approved for ("off-label use" as long as they have a strong medical rationale, are well-informed about the potential risks and benefits, and discuss the off-label use with the patient and obtain their informed consent; however, they should always practice within the standard of care for their medical field.
Key points about off-label drug use:
Legality:
It is legal for doctors to prescribe drugs off-label.
Informed decision:
Doctors should thoroughly research the potential benefits and risks of the off-label use before prescribing.
Patient consent:
It is crucial to inform the patient about the off-label use and obtain their consent.
Medical rationale:
The decision to use a drug off-label should be based on sound medical evidence and not just anecdotal information.
Potential risks:
Off-label use may have unknown side effects or interactions with other medications.


(3)
(0)




CytoDyn Inc (CYDY) Stock Research Links


  1.  
  2.  


  3.  
  4.  
  5.  






Investors Hangout

Home

Mailbox

Message Boards

Favorites

Whats Hot

Blog

Settings

Privacy Policy

Terms and Conditions

Disclaimer

Contact Us

Whats Hot

Recent Activity

Most Viewed Boards

Most Viewed Posts

Most Posted Boards

Most Followed

Top Boards

Newest Boards

Newest Members

Investors Hangout Message Boards

Welcome To Investors Hangout

Stock Message Boards

American Stock Exchange (AMEX)

NASDAQ Stock Exchange (NASDAQ)

New York Stock Exchange (NYSE)

Penny Stocks - (OTC)

User Boards

The Hangout

Private

Global Markets

Australian Securities Exchange (ASX)

Euronext Amsterdam (AMS)

Euronext Brussels (BRU)

Euronext Lisbon (LIS)

Euronext Paris (PAR)

Foreign Exchange (FOREX)

Hong Kong Stock Exchange (HKEX)

London Stock Exchange (LSE)

Milan Stock Exchange (MLSE)

New Zealand Exchange (NZX)

Singapore Stock Exchange (SGX)

Toronto Stock Exchange (TSX)

Contact Investors Hangout

Email Us

Follow Investors Hangout

Twitter

YouTube

Facebook

Market Data powered by QuoteMedia. Copyright © 2025. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges).
Analyst Ratings & Earnings by Zacks. RT=Real-Time, EOD=End of Day, PD=Previous Day. Terms of Use.

© 2025 Copyright Investors Hangout, LLC All Rights Reserved.

Privacy Policy |Do Not Sell My Information | Terms & Conditions | Disclaimer | Help | Contact Us